Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Synergy Trial
NCT01966276Phase 2Unknown
- Sponsor
- K-PAX Pharmaceuticals, Inc.
- Start
- Nov 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methylphenidate hydrochloride extended-release chewable tablet in myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS), sponsored by K-PAX Pharmaceuticals, Inc.. Status: unknown.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS)
Beyond the preview
Go deeper on NCT01966276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01966276.